Overview
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Eligibility
Inclusion Criteria:
- Aged 18-55 years
- Currently prescribed stimulant medication for ADHD
- Experiencing: sleep difficulty, irritability, anxiety, brain fog
- Stable medication dose ≥3 months
- Healthy with no uncontrolled chronic conditions
- Stable on supplements ≥3 months if applicable
- US resident
- Willing to maintain current habits
Exclusion Criteria:
- Chronic conditions (e.g. cancer, mental illness)
- Use of psychiatric medications besides stimulants
- Pregnancy, breastfeeding, thyroid, liver, kidney conditions
- Recent smokers or heavy alcohol use
- Night shift workers
- Participation in other clinical trials
- Allergies to product ingredients